Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?

被引:0
|
作者
Lee, Minna K. [1 ]
Robson, Mark E. [2 ,3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, 300 E 66th St,Room 813, New York, NY 10065 USA
来源
基金
美国国家卫生研究院;
关键词
RADIOTHERAPY; MASTECTOMY;
D O I
10.1093/jnci/djad129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1243 / 1245
页数:3
相关论文
共 50 条
  • [31] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    van Sprundel, TC
    Schmidt, MK
    Rookus, MA
    Brohet, R
    van Asperen, CJ
    Rutgers, EJT
    van't Veer, L
    Tollenaar, RAEM
    BRITISH JOURNAL OF CANCER, 2005, 93 (03) : 287 - 292
  • [32] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    T C van Sprundel
    M K Schmidt
    M A Rookus
    R Brohet
    C J van Asperen
    E J Th Rutgers
    L J van‘t Veer
    R A E M Tollenaar
    British Journal of Cancer, 2005, 93 : 287 - 292
  • [33] BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
    Sun, Jie
    Chu, Futao
    Pan, Jiani
    Zhang, Yaxin
    Yao, Lu
    Chen, Jiuan
    Hu, Li
    Zhang, Juan
    Xu, Ye
    Wang, Xiaojia
    Cao, Wenming
    Xie, Yuntao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (05) : 991 - +
  • [34] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [35] Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: impact of adjuvant systemic treatment
    Hooning, M.
    Jager, A.
    Koppert, L.
    Van Deurzen, C.
    Collee, M.
    Hollestelle, A.
    Seynaeve, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S140 - S140
  • [36] Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
    KA Phillips
    RL Milne
    MA Rookus
    D Goldgar
    M Friedlander
    SA McLachlan
    S Buys
    AC Antoniou
    K Birch
    MB Terry
    DF Easton
    P Weideman
    M Daly
    N Andrieu
    EM John
    MJ Hooning
    IL Andrulis
    T Caldes
    H Olsson
    JL Hopper
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [37] Re: Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
    Eisinger, Francois
    Huiart, Laetitia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04):
  • [38] Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer
    Evron, E.
    Ben-David, A. M.
    Goldberg, H.
    Fried, G.
    Kaufman, B.
    Catane, R.
    Pfeffer, M. R.
    Geffen, D. B.
    Chernobelsky, P.
    Karni, T.
    Abdah-Bortnyak, R.
    Rosengarten, O.
    Matceyevsky, D.
    Inbar, M.
    Kuten, A.
    Corn, B. W.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 412 - 417
  • [39] Radiation therapy and the risk of contralateral breast cancer
    Haffty, BG
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04): : 920 - 921
  • [40] Risk of primary and contralateral breast cancer in BRCA1/2 mutation carriers previously affected with ovarian cancer
    Heemskerk-Gerritsen, B. A. M.
    Hooning, M. J.
    van Doorn, H. C.
    Collee, M.
    Koppert, L. B.
    Jager, A.
    van den Ouweland, A. M. W.
    Seynaeve, C.
    Kriege, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 528 - 528